Entera Bio Ltd. of JERUSALEM, L3, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-02. The offering totals $6.6M, of which $6.6M was reported sold. Industry: Biotechnology.
Showing 25 of 27 people.
| Name | Role | Location |
|---|---|---|
| Sean Ellis | Director | Jerusalem, L3 |
| Roger Garceau | Director | Jerusalem, L3 |
| Gerald Lieberman | Director | Plymouth, MN |
| Yonatan Malca | Director | CAESAREA, L3 |
| Ron Mayron | Director | CAESAREA, L3 |
| Gerald M. Ostrov | Director | Jerusalem, L3 |
| Haya Taitel | Director | Jerusalem, L3 |
| Miranda Toledano | Director | Irvine, CA |
| Hillel Galitzer | Executive Officer | Jerusalem, L3 |
| Arthur Santora | Executive Officer | Jerusalem, L3 |
| Miranda Toledano | Executive Officer | Irvine, CA |
| Dana Yaacov-Garbeli | Executive Officer | Jerusalem, L3 |
| Adam Gridley | Director | Lexington, MA |
| Adam Gridley | Executive Officer | Lexington, MA |
| Roger Garceau | Executive Officer | Jerusalem, L3 |
| Faith Charles | Director | Houston, TX |
| Zeev Bronfeld | Director | M.P. Misgav, L3 |
| Gerald Ostrov | Director | Tel Aviv, L3 |
| Dana Yaacov | Executive Officer | JERUSALEM, L3 |
| Phillip Schwartz | Director | JERUSALEM, L3 |
| Phillip Schwartz | Executive Officer | JERUSALEM, L3 |
| David M Ben Ami | Director | Jerusalem, L3 |
| Roger M Garceau | Director | Jerusalem, L3 |
| Chaim M Davis | Director | Jerusalem, L3 |
| Luke M Beshar | Director | Jerusalem, L3 |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2019-12-26 | D | $13.5M | $13.5M |
| 2017-10-19 | D | $7.0M | $2.0M |